|
|
|
|
Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients |
Authors: Hemminki, K.; Müller-Myhsok, B.; Lichtner, P.; Engel, C.; Chen, B. W.; Burwinkel, B.; Försti, A.; Sutter, C.; Wappenschmidt, B.; Hellebrand, H.; Illig, T.; Arnold, N.; Niederacher, D.; Dworniczak, B.; Deissler, H.; Kast, K.; Gadzicki, D.; Meitinger, T.; Wichmann, H. E.; Kiechle, M.; Bartram, C. R.; Schmutzler, R. K.; Meindl, A. | Date of Publication (YYYY-MM-DD): 2010-06-15 | Title of Journal: International Journal of Cancer | Volume: 126 | Issue / Number: 12 | Start Page: 2858 | End Page: 2862 | Document Type: Article | ID: 477353.0 |
|
|
|
|
|
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene |
Authors: Meindl, A.; Hellebrand, H.; Wiek, C.; Erven, V.; Wappenschmidt, B.; Niederacher, D.; Freund, M.; Lichtner, P.; Hartmann, L.; Schaal, H.; Ramser, J.; Honisch, E.; Kubisch, C.; Wichmann, H. E.; Kast, K.; Deissler, H.; Engel, C.; Müller-Myhsok, B.; Neveling, K.; Kiechle, M.; Mathew, C. G.; Schindler, D.; Schmutzler, R. K.; Hanenberg, H. | Date of Publication (YYYY-MM-DD): 2010-05 | Title of Journal: Nature Genetics | Volume: 42 | Issue / Number: 5 | Start Page: 410 | End Page: 414 | Document Type: Article | ID: 477357.0 |
|
|
|
|
|
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. |
Authors: Tchatchou, S.; Riedel, A.; Lyer, S.; Schmutzhard, J.; Strobel-Freidekind, O.; Gronert-Sum, S.; Mietag, C.; D'Amato, M.; Schlehe, B.; Hemminki, K.; Sutter, C.; Ditsch, N.; Blackburn, A.; Hill, L. Z.; Jerry, D. J.; Bugert, P.; Weber, B. H.; Niederacher, D.; Arnold, N.; Varon-Mateeva, R.; Wappenschmidt, B.; Schmutzler, R. K.; Engel, C.; Meindl, A.; Bartram, C. R.; Mollenhauer, J.; Burwinkel, B. | Date of Publication (YYYY-MM-DD): 2010-01-01 | Title of Journal: Human Mutations | Volume: 31 | Issue / Number: 1 | Start Page: 60 | End Page: 66 | Document Type: Article | ID: 541906.0 |
|
|
|
|
|
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker |
Authors: Sadr-Nabavi, A.; Ramser, J.; Volkmann, J.; Naehrig, J.; Wiesmann, F.; Betz, B.; Hellebrand, H.; Engert, S.; Seitz, S.; Kreutzfeld, R.; Sasaki, T.; Arnold, N.; Schmutzler, R.; Kiechle, M.; Niederacher, D.; Harbeck, N.; Dahl, E.; Meindl, A. | Date of Publication (YYYY-MM-DD): 2009-04-01 | Title of Journal: International Journal of Cancer | Volume: 124 | Issue / Number: 7 | Start Page: 1727 | End Page: 1735 | Document Type: Article | ID: 423858.0 |
|
|
The scope and number of records on eDoc is subject
to the collection policies defined by each institute
- see "info" button in the collection browse view.
|
|